martes, 3 de octubre de 2023

Long-Awaited Guidance on FDAMA 115: Confirmatory Evidence Finally Has Its Moment (to be Crossed Off the FDA’s Guidance To-Do List) By Charles G. Raver & James E. Valentine & Frank J. Sasinowski —

https://www.thefdalawblog.com/2023/10/long-awaited-guidance-on-fdama-115-confirmatory-evidence-finally-has-its-moment-to-be-crossed-off-the-fdas-guidance-to-do-list/?utm_source=rss&utm_medium=rss&utm_campaign=long-awaited-guidance-on-fdama-115-confirmatory-evidence-finally-has-its-moment-to-be-crossed-off-the-fdas-guidance-to-do-list

No hay comentarios: